News

For a long time, scientists depended on luck to find new proteins. In 1840, for example, the Friedrich Ludwig Hünefeld, a ...
Fintel reports that on June 11, 2025, Raymond James initiated coverage of Avidity Biosciences (NasdaqGM:RNA) with a Strong Buy recommendation. Analyst Price Forecast Suggests 102.62% Upside As of June ...
Scientists at St. Jude Children's Research Hospital, the National Center for Genomic Analysis and the University of Adelaide ...
June 11, 2025) Single-cell RNA sequencing provides scientists with important information about gene expression in health and ...
Avidity Biosciences (NASDAQ:RNA – Free Report) had its price target increased by Barclays from $57.00 to $59.00 in a report published on Tuesday morning,Benzinga reports. Barclays currently has an ...
Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $65.42, along with a high estimate of $75.00 and a low estimate of $54.00. Surpassing the ...
Alida Biosciences, a leader in next-generation RNA modification analysis, is proud to announce its first official service provider: the Genomic and RNA Profiling (GARP) Core at Baylor College of ...